AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) fell to a greater than expected loss for the first quarter of 22 cents per diluted share compared with earnings of 39 cents per diluted share in the year ago period. The stock price plunged $3.65 to close at $22.03.
AMAG Pharmaceuticals falls short
May 03, 2016 at 19:12 PM EDT